BENEKLİ, M. Et Al. 2015. Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population. ONCOTARGETS AND THERAPY , vol.8 , 1-5.

BENEKLİ, M., YALÇIN, Ş., ÖZKAN, M., ELKIRAN, E. T., Sevinc, A., ÇABUK, D., ... COŞKUN, H. Ş.(2015). Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population. ONCOTARGETS AND THERAPY , vol.8, 1-5.

BENEKLİ, MUSTAFA Et Al. "Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population," ONCOTARGETS AND THERAPY , vol.8, 1-5, 2015

BENEKLİ, MUSTAFA Et Al. "Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population." ONCOTARGETS AND THERAPY , vol.8, pp.1-5, 2015

BENEKLİ, M. Et Al. (2015) . "Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population." ONCOTARGETS AND THERAPY , vol.8, pp.1-5.

@article{article, author={MUSTAFA BENEKLİ Et Al. }, title={Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population}, journal={ONCOTARGETS AND THERAPY}, year=2015, pages={1-5} }